Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis”

675 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 675 results

Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Study completedNCT01094158
What this trial is testing

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisMetabolic Syndrome
Galmed Medical Reserch 60
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Early research (Phase 1)Study completedNCT03610945
What this trial is testing

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT01205087
What this trial is testing

Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

Who this might be right for
Nonalcoholic Steatohepatitis
Hadassah Medical Organization 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Early research (Phase 1)Study completedNCT04187339
What this trial is testing

Study of NGM395 in Adult Participants

Who this might be right for
ObesityNAFLD
NGM Biopharmaceuticals, Inc 38
Testing effectiveness (Phase 2)UnknownNCT05338034
What this trial is testing

Phase 2a Study of HPG1860 in Subjects With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hepagene (Shanghai) Co., Ltd. 89
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Testing effectiveness (Phase 2)UnknownNCT04772352
What this trial is testing

Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ningbo No. 1 Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Testing effectiveness (Phase 2)Study completedNCT02217475
What this trial is testing

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 289
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Not applicableNot Yet RecruitingNCT07168551
What this trial is testing

Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients

Who this might be right for
HyperuricemiaNAFLD (Nonalcoholic Fatty Liver Disease)Liver Fibrosis
Assiut University 111
Load More Results